SCHEMBL8635641

SCHEMBL8635641

COc1cc(NC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)c(C(N)=O)cc1OC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.62
KDM4E B2RXH2 9/20 0.62
HPGD P15428 9/20 0.62
NPSR1 Q6W5P4 4/20 0.62
GAA P10253 3/20 0.62
LMNA P02545 2/20 0.62
MAPT P10636 4/20 0.59
HTT P42858 4/20 0.57
CYP1A2 P05177 3/20 0.57
CYP2C19 P33261 3/20 0.57
CYP3A4 P08684 3/20 0.57
SMN1; SMN2 Q16637 5/20 0.56
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA9 Q16790 1/20 0.56
MEN1 O00255 5/20 0.55
KMT2A Q03164 5/20 0.55
PSMB11 A5LHX3 1/20 0.54
PSMA7 O14818 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8635626 1.00 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDNPSR1GAA
SCHEMBL8638748 0.89 ALDH1A1 (0.67) ALDH1A1KDM4EHPGDNPSR1GAA
SCHEMBL8638736 0.89 ALDH1A1 (0.67) ALDH1A1KDM4EHPGDNPSR1GAA
SCHEMBL8641773 0.87 ALDH1A1 (0.65) ALDH1A1KDM4EHPGDNPSR1GAA
SCHEMBL8641782 0.87 ALDH1A1 (0.65) ALDH1A1KDM4EHPGDNPSR1GAA
SCHEMBL8635343 0.85 ALDH1A1 (0.80) ALDH1A1KDM4EHPGDNPSR1GAA
SCHEMBL8635335 0.85 ALDH1A1 (0.80) ALDH1A1KDM4EHPGDNPSR1GAA
SCHEMBL8640013 0.82 MEN1 (0.70) ALDH1A1KDM4EHPGDNPSR1GAA
SCHEMBL8640000 0.82 MEN1 (0.70) ALDH1A1KDM4EHPGDNPSR1GAA
SCHEMBL20538416 0.81 ALDH1A1 (0.67) ALDH1A1KDM4EHPGDNPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0855387-A1 2-ACYLAMINOBENZAMIDE DERIVATIVES AND PREVENTIVE AND REMEDY FOR DISEASES CAUSED BY THE SUPERMULTIPLICATION OF VASCULAR INTIMAL CELLS KISSEI PHARMACEUTICAL CO., LTD. (JP) 1998-07-29 EP disclosed